FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Victoria Polonis

Research Profile

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Concepts & Ideas

Phenomena

Virus Internalization

Physiology

Cross Reactions

Co-author Network

Publications

TOP 3
Guofen Gao; Kristina K Peachman; Victoria R Polonis; Mangala Rao; Carl R Alving; Lindsay Wieczorek; Venigalla B Rao
Designing a soluble near full-length HIV-1 gp41 trimer.
Robert McLinden; Robert Paris; Victoria R Polonis; Cecilia Shikuma; Zhaohui Su; Nicole Close; David Margolis; Jerome Kim
Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).
Josephine H Cox; Patricia Earl; Leigh Anne Eller; Guido Ferrari; Maria G Ferrari; Lydia Hart; Linda L Jagodzinski; Jerome H Kim; Ellen Kuta; James R Lane; David Montefiori; Bernard Moss; Stephanie Parrish; Doan-Trang Pham; Victoria R Polonis; Silvia Ratto-Kim; Deborah L Birx; Jean D Boyer; David B Weiner; Thomas C VanCott
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Victoria Polonis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Guofen Gao; Kristina K Peachman; Victoria R Polonis; Mangala Rao; Carl R Alving; Lindsay Wieczorek; Venigalla B Rao
Designing a soluble near full-length HIV-1 gp41 trimer.
The Journal of biological chemistry 2013;288(1):234-46.
2012: Robert McLinden; Robert Paris; Victoria R Polonis; Cecilia Shikuma; Zhaohui Su; Nicole Close; David Margolis; Jerome Kim
Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).
AIDS (London, England) 2012;26(11):1452.
2012: Josephine H Cox; Patricia Earl; Leigh Anne Eller; Guido Ferrari; Maria G Ferrari; Lydia Hart; Linda L Jagodzinski; Jerome H Kim; Ellen Kuta; James R Lane; David Montefiori; Bernard Moss; Stephanie Parrish; Doan-Trang Pham; Victoria R Polonis; Silvia Ratto-Kim; Deborah L Birx; Jean D Boyer; David B Weiner; Thomas C VanCott
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
Vaccine 2012;30(10):1830-40.
2012: Robert Paris; Punnee Pitisuttithum; Victoria R Polonis; Silvia Ratto-Kim; Anna Sambor; Henry A Stephens; Prasert Thongcharoen; Sasitorn Bejrachandra; Arthur E Brown; Mark de Souza; Donald Francis; Sanjay Gurunathan; Chitraporn Karnasuta; Jerome H Kim; Sorachai Nitayaphan
HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.
Vaccine 2012;30(5):832-6.
2012: Robert J McLinden; Robert M Paris; Victoria R Polonis; Cecilia M Shikuma; Zhaohui Su; Nicole C Close; David M Margolis; Jerome H Kim
Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).
AIDS (London, England) 2012;26(1):1-9.
2012: Silvia Ratto-Kim; Merlin L Robb; Eddy Sayeed; Doris Thelian; Anais Valencia-Micolta; Josephine H Cox; Jeffrey R Currier; Patricia L Earl; Jean-Louis Excler; Jerome H Kim; Vicky Lo; Nelson L Michael; Bernard Moss; Victoria R Polonis; Mary A Marovich
Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.
PloS one 2012;7(9):e45840.
2012: Mei-Yun Zhang; Javier Guenaga; Jingjing Li; Yuxing Li; Seth H Pincus; Victoria R Polonis; Andrew Rosa Borges; Ruth M Ruprecht; Yanping Wang; Jennifer D Watkins; Richard Wilson; Zheng Yang; Tingting Yuan; Dimiter S Dimitrov
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
PloS one 2012;7(9):e44241.
2012: Anton M Sholukh; Hemant K Vyas; Jennifer D Watkins; Peter H Schur; Vivekanandan Shanmuganathan; Sosthène S Essono; Girish Hemashettar; Shiu-Lok Hu; Michael Humbert; Maria Kahn; David C Montefiori; Muhammad M Mukhtar; Victoria R Polonis; Ruth M Ruprecht
Isolation of monoclonal antibodies with predetermined conformational epitope specificity.
PloS one 2012;7(6):e38943.
2012: Bruce K Brown; Jeffrey Currier; John C Kappes; Gustavo Kijak; Kara Lombardi; Mary A Marovich; Nelson Michael; David C Montefiori; Viseth Ngauy; Christina Ochsenbauer; Maggie Wesberry; Lindsay Wieczorek; Victoria R Polonis
The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization.
PloS one 2012;7(4):e29454.
2011: Muhammad Bakari; Gunnel Biberfeld; Andreas Bråve; Deus Buma; Patricia Earl; Joel Francis; Karina Godoy-Ramirez; Mohamed Janabi; Agricola Joachim; Eligius Lyamuya; Mary A Marovich; Fred Mhalu; Candida Moshiro; Charlotta Nilsson; Kisali Pallangyo; Victoria R Polonis; Merlin Robb; Said Aboud; Eric Aris; Britta Wahren; Eric Sandström
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania.
Vaccine 2011;29(46):8417-28.
2011: Zoltan Beck; Bruce K Brown; Gary R Matyas; Victoria R Polonis; Mangala Rao; Carl R Alving
Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: effects of antibodies and complement.
Virology 2011;412(2):441-7.
2011: Michael A Eller; Emil Lesho; Josephine H Cox; Jeffrey R Currier; Janice M Darden; Nelson L Michael; Sheila Peel; Victoria R Polonis; Merlin L Robb; Bonnie M Slike; Maryanne Vahey; Zhining Wang; Mary A Marovich
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells.
PloS one 2011;6(9):e24254.
2011: Peter Oballah; Benson Ouma; Merlin L Robb; Fred Wabwire-Mangen; Bruce K Brown; Mark de Souza; Leigh Anne Eller; Michael A Eller; Britta Flach; Hannah N Kibuuka; Nelson L Michael; David Montefiori; Victoria R Polonis
B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses.
PloS one 2011;6(8):e22653.
2010: Kristina K Peachman; Lindsay Wieczorek; Victoria R Polonis; Carl R Alving; Mangala Rao
The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies.
Virology 2010;408(2):213-23.
2010: Andrew Rosa Borges; Lindsay Wieczorek; Benitra Johnson; Alan J Benesi; Bruce K Brown; Richard D Kensinger; Fred C Krebs; Brian Wigdahl; Robert Blumenthal; Anu Puri; Francine E McCutchan; Deborah L Birx; Victoria R Polonis; Cara-Lynne Schengrund
Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.
Virology 2010;408(1):80-8.
2010: Kristina K Peachman; Lindsay Wieczorek; Gary R Matyas; Victoria R Polonis; Carl R Alving; Mangala Rao
The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization.
Viral immunology 2010;23(6):627-32.
2010: Gary R Matyas; Lindsay Wieczorek; Divya Bansal; Agnes-Laurence Chenine; eric sanders-buell; Sodsai Tovanabutra; Jerome H Kim; Victoria R Polonis; Carl R Alving
Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines.
Biochemical and biophysical research communications 2010;402(4):808-12.
2010: Mei-Yun Zhang; Andrew Rosa Borges; Roger G Ptak; Yanping Wang; Antony S Dimitrov; S Munir Alam; Lindsay Wieczorek; Peter Bouma; Timothy Fouts; Shibo Jiang; Victoria R Polonis; Barton F Haynes; Gerald V Quinnan; David C Montefiori; Dimiter S Dimitrov
Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1.
mAbs 2010;2(3):266-74.
2010: Michael S Seaman; Holly Janes; Natalie Hawkins; Lauren Grandpre; Colleen Devoy; Ayush Giri; Rory T Coffey; Linda Harris; Blake Wood; Marcus G Daniels; Tanmoy Bhattacharya; Alan Lapedes; Victoria R Polonis; Francine E McCutchan; Peter B Gilbert; Steve G Self; Bette T Korber; David C Montefiori; John R Mascola
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.
Journal of virology 2010;84(3):1439-52.
2010: Jeffrey R Currier; Viseth Ngauy; Mark S de Souza; Silvia Ratto-Kim; Josephine H Cox; Victoria R Polonis; Patricia Earl; Bernard Moss; Sheila Peel; Bonnie Slike; Somchai Sriplienchan; Prasert Thongcharoen; Robert M Paris; Merlin L Robb; Jerome Kim; Nelson L Michael; Mary A Marovich
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate.
PloS one 2010;5(11):e13983.
2010: Bruce K Brown; Josephine Cox; Anita Gillis; Thomas C VanCott; Mary Marovich; Mark Milazzo; Tanya Santelli Antonille; Lindsay Wieczorek; Kelly T McKee; Karen Metcalfe; Raburn M Mallory; Deborah Birx; Victoria R Polonis; Merlin L Robb
Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults.
PloS one 2010;5(11):e13849.
2009: Gary R Matyas; Lindsay Wieczorek; Zoltan Beck; Christina Ochsenbauer-Jambor; John C Kappes; Nelson L Michael; Victoria R Polonis; Carl R Alving
Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
AIDS (London, England) 2009;23(16):2069-77.
2009: Victoria R Polonis; Hanneke Schuitemaker; Evelien M Bunnik; Bruce K Brown; Gabriella Scarlatti
Impact of host cell variation on the neutralization of HIV-1 in vitro.
Current opinion in HIV and AIDS 2009;4(5):400-7.
2009: Smita S Kulkarni; Alan Lapedes; Haili Tang; S Gnanakaran; Marcus G Daniels; Ming Zhang; Tanmoy Bhattacharya; Ming Li; Victoria R Polonis; Francine E McCutchan; Lynn Morris; Dennis Ellenberger; Salvatore T Butera; Robert Bollinger; Bette T Korber; Ramesh S Paranjape; David C Montefiori
Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India.
Virology 2009;385(2):505-20.
2009: Zoltan Beck; Bruce K Brown; Lindsay Wieczorek; Kristina K Peachman; Gary R Matyas; Victoria R Polonis; Mangala Rao; Carl R Alving
Human erythrocytes selectively bind and enrich infectious HIV-1 virions.
PloS one 2009;4(12):e8297.
2009: Jorge C G Blanco; Lioubov M Pletneva; Lindsay Wieczorek; Dimple Khetawat; Tzanko S Stantchev; Christopher C Broder; Victoria R Polonis; Gregory A Prince
Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.
Virology journal 2009;6():57.
2008: Thippawan Chuenchitra; Chantapong Wasi; Mark de Souza; Sorachai Nitayaphan; Suda Louisirirotchanakul; Ruengpung Sutthent; Arthur E Brown; Deborah L Birx; Victoria R Polonis
Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression.
The Southeast Asian journal of tropical medicine and public health 2008;39(5):856-62.
2008: Bruce K Brown; Lindsay Wieczorek; eric sanders-buell; Andrew Rosa Borges; Merlin L Robb; Deborah L Birx; Nelson L Michael; Francine E McCutchan; Victoria R Polonis
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.
Virology 2008;375(2):529-38.
2008: Victoria R Polonis; Bruce K Brown; Andrew Rosa Borges; Susan Zolla-Pazner; Dimiter S Dimitrov; Mei-Yun Zhang; Susan W Barnett; Ruth Ruprecht; Gabriella Scarlatti; Eva Maria Fenyö; David C Montefiori; Francine E McCutchan; Nelson L Michael
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.
Virology 2008;375(2):315-20.
2007: Suda Louisirirotchanakul; Ruengpung Sutthent; Chantapong Wasi; Thippawan Chuenchitra; Sorachai Nitayaphan; Arthur E Brown; Victoria R Polonis; Emi E Nakayama; Tatsuo Shioda; Huanliang Liu; Yutaka Takebe
Host genetic analysis of HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression.
AIDS research and human retroviruses 2007;23(12):1605-8.
2007: Prasert Thongcharoen; Vinai Suriyanon; Robert M Paris; Chirasak Khamboonruang; Mark de Souza; Silvia Ratto-Kim; Chitraporn Karnasuta; Victoria R Polonis; Lynn Baglyos; Raphaelle El Habib; Sanjay Gurunathan; Susan Barnett; Arthur E Brown; Deborah L Birx; John G McNeil; Jerome H Kim
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):48-55.
2007: Thomas J Ketas; Susan M Schader; Juan Zurita; Esther Teo; Victoria R Polonis; Min Lu; Per Johan Klasse; John P Moore
Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
Virology 2007;364(2):431-40.
2007: Alleluiah Rutebemberwa; J W Bess; B Brown; M Arroyo; Michael A Eller; Bonnie M Slike; Victoria R Polonis; Francine E McCutchan; Jeffrey R Currier; Deborah L Birx; Merlin Robb; Mary A Marovich; J D Lifson; Josephine H Cox
Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses.
AIDS research and human retroviruses 2007;23(4):532-42.
2007: Bruce K Brown; Nicos Karasavvas; Zoltan Beck; Gary R Matyas; Deborah L Birx; Victoria R Polonis; Carl R Alving
Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.
Journal of virology 2007;81(4):2087-91.
2006: Ming Li; Jesus F Salazar-Gonzalez; Cynthia A Derdeyn; Lynn Morris; Carolyn Williamson; James E Robinson; Julie M Decker; Yingying Li; Maria G Salazar; Victoria R Polonis; Koleka Patience Mlisana; Salim Abdool Karim; Kunxue Hong; Kelli M Greene; Miroslawa Bilska; Jintao Zhou; Susan Allen; Elwyn Chomba; Joseph Mulenga; Cheswa Vwalika; Feng Gao; Ming Zhang; Bette T Korber; Eric Hunter; Beatrice H Hahn; David C Montefiori
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa.
Journal of virology 2006;80(23):11776-90.
2005: Francine E McCutchan; Michael Hoelscher; Sodsai Tovanabutra; Sucheep Piyasirisilp; eric sanders-buell; G Ramos; Linda L Jagodzinski; Victoria R Polonis; Leonard Maboko; Donan Mmbando; Oliver Hoffmann; Gabriele Riedner; Frank von Sonnenburg; Merlin Robb; Deborah L Birx
In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection.
Journal of virology 2005;79(18):11693-704.
2005: Ming Li; Feng Gao; John R Mascola; Leonidas Stamatatos; Victoria R Polonis; Marguerite Koutsoukos; Gerald Voss; Paul A Goepfert; Peter Gilbert; Kelli M Greene; Miroslawa Bilska; Denise L Kothe; Jesus F Salazar-Gonzalez; Xiping Wei; Julie M Decker; Beatrice H Hahn; David C Montefiori
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.
Journal of virology 2005;79(16):10108-25.
2005: John R Mascola; Patricia D'Souza; Peter Gilbert; Beatrice H Hahn; Nancy Haigwood; Lynn Morris; Christos J Petropoulos; Victoria R Polonis; Marcella Sarzotti; David C Montefiori
Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines.
Journal of virology 2005;79(16):10103-7.
2005: Bruce K Brown; Janice M Darden; Sodsai Tovanabutra; Tamara Oblander; Julie Frost; eric sanders-buell; Mark de Souza; Deborah L Birx; Francine E McCutchan; Victoria R Polonis
Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.
Journal of virology 2005;79(10):6089-101.
2004: Sorachai Nitayaphan; Punnee Pitisuttithum; Chitraporn Karnasuta; Chirapa Eamsila; Mark de Souza; Patricia Morgan; Victoria R Polonis; Michael W Benenson; Thomas C VanCott; Silvia Ratto-Kim; Jerome Kim; Darawan Thapinta; Robin P Garner; Valai Bussaratid; Pricha Singharaj; Raphaelle El Habib; Sanjay Gurunathan; William L Heyward; Deborah L Birx; John McNeil; Arthur E Brown
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.
The Journal of infectious diseases 2004;190(4):702-6.
2004: Ronnarit Haponsaph; Janice M Darden; Somsak Chantakulkij; Nongluck Sannoi; Mark de Souza; Arthur E Brown; Deborah L Birx; Victoria R Polonis; Kovit Pattanapanyasat
In vitro susceptibility of Thai seronegative donor CD8+ T lymphocytes to human immunodeficiency virus-1 (HIV-1) infection.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2004;22(1):39-48.
2003: Jerome H Kim; Punnee Pitisuttithum; Chirasak Kamboonruang; Thippawan Chuenchitra; John R Mascola; Sarah Schlesinger Frankel; Mark de Souza; Victoria R Polonis; Robert McLinden; Anna Sambor; Arthur E Brown; Benjaluck Phonrat; Kittipong Rungruengthanakit; Anne-Marie Duliege; Merlin L Robb; John McNeil; Deborah L Birx
Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1.
AIDS research and human retroviruses 2003;19(9):807-16.
2003: Victoria R Polonis; Mark de Souza; Janice M Darden; Somsak Chantakulkij; Thippawan Chuenchitra; Sorachai Nitayaphan; Arthur E Brown; Merlin L Robb; Deborah L Birx
Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients.
Journal of virology 2003;77(15):8570-6.
2003: Punnee Pitisuttithum; Sorachai Nitayaphan; Prasert Thongcharoen; Chirasak Khamboonruang; Jerome Kim; Mark de Souza; Thippawan Chuenchitra; Robin P Garner; Darawan Thapinta; Victoria R Polonis; Silvia Ratto-Kim; Penprapa Chanbancherd; Joseph Chiu; Deborah L Birx; Anne-Marie Duliege; John G McNeil; Arthur E Brown
Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.
The Journal of infectious diseases 2003;188(2):219-27.
2003: Thippawan Chuenchitra; Chantapong Wasi; Suda Louisirirojchanakul; Sorachai Nitayaphan; Ruengpung Sutthent; Josephine H Cox; Mark de Souza; Arthur E Brown; Deborah L Birx; Victoria R Polonis
Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression.
AIDS research and human retroviruses 2003;19(4):293-305.
2003: Ming Dong; Peng Fei Zhang; Franziska Grieder; James Lee; Govindaraj Krishnamurthy; Thomas C VanCott; Christopher C Broder; Victoria R Polonis; XIAOFANG YU; Yiming Shao; Dennis Faix; Patricia Valente; Gerald V Quinnan
Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system.
Journal of virology 2003;77(5):3119-30.
2003: Iqbal H Chowdhury; Xiao-Fan Wang; Nathaniel R Landau; Merlin L Robb; Victoria R Polonis; Deborah L Birx; Jerome H Kim
HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest.
Virology 2003;305(2):371-7.
2002: Miroslaw K Gorny; Constance Williams; Barbara Volsky; Kathy Revesz; Sandra Cohen; Victoria R Polonis; William J Honnen; Samuel C Kayman; Chavdar Krachmarov; Abraham Pinter; Susan Zolla-Pazner
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.
Journal of virology 2002;76(18):9035-45.
2001: Sodsai Tovanabutra; Victoria R Polonis; Mark de Souza; Rapee Trichavaroj; Penprapa Chanbancherd; Bohye Kim; eric sanders-buell; Sorachai Nitayaphan; A Brown; M R Robb; Deborah L Birx; Francine E McCutchan; Jean K Carr
First CRF01_AE/B recombinant of HIV-1 is found in Thailand.
AIDS (London, England) 2001;15(8):1063-5.
2001: Victoria R Polonis; Mark de Souza; Penprapa Chanbancherd; Somsak Chantakulkij; Achara Jugsudee; Lawrence D Loomis-Price; Thomas C VanCott; Robin P Garner; Lauri E Markowitz; Arthur E Brown; Deborah L Birx
HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies.
AIDS research and human retroviruses 2001;17(1):69-79.
2000: Mika Salminen; Philip K Ehrenberg; John R Mascola; Debora Elizabeth Sites (Dayhoff); R Merling; B Blake; Mark K Louder; S Hegerich; Victoria R Polonis; Deborah L Birx; Merlin L Robb; Francine E McCutchan; Nelson L Michael
Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction.
Virology 2000;278(1):103-10.
2000: George Watt; Pacharee Kantipong; Mark de Souza; Penprapa Chanbancherd; Krisada Jongsakul; R Ruangweerayud; Lawrence D Loomis-Price; Victoria R Polonis; Khin Saw Aye Myint; Deborah L Birx; Arthur E Brown; S Krishna
HIV-1 suppression during acute scrub-typhus infection.
Lancet 2000;356(9228):475-9.
2000: Janice M Darden; Victoria R Polonis; Mark de Souza; Somsak Chantakulkij; Arthur E Brown; Deborah L Birx; Kovit Pattanapanyasat
A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates.
Cytometry 2000;40(2):141-50.
1999: Nelson L Michael; S A Herman; S Kwok; K Dreyer; J Wang; C Christopherson; JP Spadoro; K K Young; Victoria R Polonis; F E McCutchan; Jean K Carr; John R Mascola; Linda L Jagodzinski; Merlin L Robb
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes.
Journal of clinical microbiology 1999;37(8):2557-63.